In: Angiogenesis, 2015, vol. 18, no. 3, p. 327-345
|
In: Biological Chemistry, ///-
|
In: Clinical Research in Cardiology, 2015, vol. 104, no. 2, p. 124-135
|
In: Cells, 2020, vol. 9, no. 7, p. 1695
The aged population is currently at its highest level in human history and is expected to increase further in the coming years. In humans, aging is accompanied by impaired angiogenesis, diminished blood flow and altered metabolism, among others. A cellular mechanism that impinges upon these manifestations of aging can be a suitable target for therapeutic intervention. Here we identify cell...
|
In: British Journal of Pharmacology, 2020, vol. 177, no. 4, p. 866–883
During angiogenesis, quiescent endothelial cells (ECs) are activated by various stimuli to form new blood vessels from pre‐existing ones in physiological and pathological conditions. Many research groups have shown that hydrogen sulfide (H2S), the newest member of the gasotransmitter family, acts as a proangiogenic factor. To date, very little is known about the regulatory role of...
|
In: Cardiovascular Revascularization Medicine, 2019, vol. 20, no. 7, p. 577–582
Background: The advent of bioresorbable vascular scaffolds (BVS) was considered as a potential improvement in percutaneous coronary intervention (PCI) after the groundbreaking development of drug eluting stents (DES). However, the clinical performance, long-term safety and efficacy of BVS in complex coronary lesions remain uncertain. COMPARE ABSORB, a multicenter, single blind, prospective ...
|
In: Pediatric Surgery International, 2014, vol. 30, no. 2, p. 223-231
|
In: Cell and Tissue Research, 2014, vol. 355, no. 3, p. 687-699
|
In: Angiogenesis, 2014, vol. 17, no. 4, p. 779-804
|
In: Journal of Neurology, 2014, vol. 261, no. 4, p. 732-737
|